Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Tong

Showing results (461-470 of 479) with videos related to

Pageof 48
Sort By:
Nature Communications|October 13, 2021
Wafer-scale functional circuits based on two dimensional semiconductors with fabrication optimized by machine learningXinyu Chen, Yufeng Xie, Yaochen Sheng, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2012
Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitorsVishal A Verma, Randall Rossman, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Journal of Medicinal Chemistry|November 4, 2016
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated PolymorphismsLing Tong, Wensheng Yu, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Guowei Zhou, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseasesVinay M Girijavallabhan, Lei Chen, Chaoyang Dai, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's DiseaseAnthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Journal of Medicinal Chemistry|February 27, 2020
Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative DiseasesLing Tong, Wenping Li, Michael Man-Chu Lo, et al.
Pageof 48

Showing results (461-470 of 479) with videos related to

Sort By:
Pageof 48
Nature Communications|October 13, 2021
Wafer-scale functional circuits based on two dimensional semiconductors with fabrication optimized by machine learningXinyu Chen, Yufeng Xie, Yaochen Sheng, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2012
Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitorsVishal A Verma, Randall Rossman, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Journal of Medicinal Chemistry|November 4, 2016
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated PolymorphismsLing Tong, Wensheng Yu, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Guowei Zhou, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseasesVinay M Girijavallabhan, Lei Chen, Chaoyang Dai, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's DiseaseAnthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Journal of Medicinal Chemistry|February 27, 2020
Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative DiseasesLing Tong, Wenping Li, Michael Man-Chu Lo, et al.
Pageof 48